Literature DB >> 26943425

A case of occult intrahepatic cholangiocarcinoma diagnosed by autopsy.

Eri Oda1, Daisuke Hashimoto2, Yuko Shiomi3,4, Koji Ohnishi5, Hiromitsu Hayashi6, Akira Chikamoto7, Motohiro Takeya8, Hideo Baba9.   

Abstract

Cancer of unknown primary is associated with unknown biology and dismal prognosis. The most common primary sites of cancer of unknown primary were usually the lungs in autopsy studies, and intrahepatic cholangiocarcinoma is rare. We describe the case of a 57-year-old male patient with systemic lymph node metastasis. Imaging examination failed to reveal primary cancer; however, immunostaining of cytokeratins 7, 19, and 20 of a metastatic axillary lymph node suggested a pancreaticobiliary cancer as a primary lesion. He died of liver abscess and sepsis, and then, autopsy indicated occult intrahepatic cholangiocarcinoma. We discuss the clinical course of this rare cholangiocarcinoma including the diagnostic procedure and also present a review of the English literature regarding patients with cancer of unknown primary.

Entities:  

Keywords:  Autopsy; Cancer of unknown primary; Intrahepatic cholangiocarcinoma

Year:  2015        PMID: 26943425      PMCID: PMC4605921          DOI: 10.1186/s40792-015-0106-5

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


Background

Carcinomas of unknown primary (CUP) represent a group of heterogeneous tumors that has no identifiable origin [1]. Despite advances in tumor pathology and imaging techniques, such as positron emission tomography (PET), CUP account for about 5 % of all cancers [2-4] and are associated with a dismal prognosis [5-8]. In such CUP cases, an autopsy is performed to find the primary site. In this report, we describe the case of a 59-year-old male patient with CUP. The patient was diagnosed with occult intrahepatic cholangiocarcinoma by autopsy. We present a review of the English literature regarding patients with cancer of unknown primary and discuss the clinical course and diagnostic examination for this occult cholangiocarcinoma case.

Case presentation

A 57-year-old male was investigated because of elevation of tumor markers (carcinoembryonic antigen (CEA) 12.9 mg/ml, carbohydrate antigen 19-9 (CA19-9) 658.5 U/ml). Enhanced computed tomography (CT) (Fig. 1a) and PET-CT (Fig. 1b) and endoscopy failed to detect a suspected primary lesion. As CT revealed multiple swollen abdominal (Fig. 1c) and axillary lymph nodes (Fig. 2a), an excisional biopsy of an axillary lymph node was performed. The histological diagnosis of the lymph node was a metastasis of adenocarcinoma (Fig. 2b). Because immunohistochemistry of the lymph node for cytokeratin (CK) 7 (Fig. 2c) and CK19 was positive and that for CK20 was almost negative (Fig. 2d), pancreaticobiliary cancer was suspected as primary lesion. Then, endoscopic retrograde cholangiopancreatography (ERCP) was performed; nevertheless, the primary lesion was not discovered. Biopsy from epithelium of the bile duct was obtained during ERCP, and the malignant cell was not found. Combination chemotherapy of gemcitabine and cisplatin was introduced; however, his disease had progressed. The patient died of liver abscess and sepsis 10 months after the introduction of chemotherapy. All diagnostic modalities which the patient underwent to obtain a diagnosis are listed in Table 1.
Fig. 1

Enhanced CT and PET-CT. CT (a) and PET-CT (b) failed to detect the tumor in the liver. CT revealed multiple swollen abdominal lymph nodes (arrows) (c)

Fig. 2

An excisional biopsy of axillary lymph node. CT (a) detected a swollen axillary lymph node (arrow) and an excisional biopsy was performed. The histological diagnosis of the lymph node was a metastasis of adenocarcinoma (b). Immunohistochemistry for CK7 was positive (c) and that for CK20 was almost negative (d). Bar 10 μm

Table 1

Diagnostic modalities which the patient underwent to obtain a diagnosis

ExaminationFindings
Tumor markerCEA 12.9 mg/ml
CA19-9 658.5 U/ml
Gastrointestinal and colorectal endoscopyNo significant findings
CTMultiple swollen abdominal and axillary lymph nodes
PET-CTMultiple swollen abdominal and axillary lymph nodes without abnormal uptake
Immunohistochemistry of the lymph nodeCK7 and CK19 were positive
CK20 was almost negative
ERCPNo significant findings
Biopsy from epithelium of the bile ductNo malignancy
Enhanced CT and PET-CT. CT (a) and PET-CT (b) failed to detect the tumor in the liver. CT revealed multiple swollen abdominal lymph nodes (arrows) (c) An excisional biopsy of axillary lymph node. CT (a) detected a swollen axillary lymph node (arrow) and an excisional biopsy was performed. The histological diagnosis of the lymph node was a metastasis of adenocarcinoma (b). Immunohistochemistry for CK7 was positive (c) and that for CK20 was almost negative (d). Bar 10 μm Diagnostic modalities which the patient underwent to obtain a diagnosis Autopsy was performed to find the primary lesion. Macroscopically, a gray-white colored, ill-defined solid tumor in the lateral segment of the liver was found, invading the diaphragm (Fig. 3a). Pathological diagnosis was intrahepatic cholangiocarcinoma (Fig. 3b). Immunohistochemistry revealed that these tumor cells were positive for CK7 (Fig. 3c) and CK19 and were negative for CK20 (Fig. 3d), as well as axillary lymph node metastasis.
Fig. 3

Postmortem findings. Macroscopically, a solid tumor (arrowheads) in the lateral segment of the liver was discovered (a). At histology, intrahepatic cholangiocarcinoma was observed (b). Immunohistochemistry of the lymph node for CK7 (c) and CK20 (d) was similar. Bar 10 μm

Postmortem findings. Macroscopically, a solid tumor (arrowheads) in the lateral segment of the liver was discovered (a). At histology, intrahepatic cholangiocarcinoma was observed (b). Immunohistochemistry of the lymph node for CK7 (c) and CK20 (d) was similar. Bar 10 μm We reviewed recent English literature regarding patients with CUP [9-12] (Table 2). The most common pathology of CUP was adenocarcinoma, and the most common primary sites found by autopsy were usually the lungs followed by the pancreas. The possible reason why the lung is the common primary site in CUP is that small cell carcinoma is likely to develop metastasis even in its early stages [13]. However, we are not aware of similar cases with intrahepatic cholangiocarcinoma. The advantages of an autopsy in such cases are to identify the primary site, to provide closure for family members, and to correlate findings with antemortem investigations [9, 14, 15], in spite of the damaging disadvantage of the body. Autopsy can still play an important role, especially the problem-oriented autopsy in which a clinician provides clinical diagnoses and raises a specific question to be answered by the pathologist, like the present case [16, 17].
Table 2

Recent literature summary of studies of patients with cancer of unknown primary

AuthorTotal number of patientsCommon pathology (no.)Autopsy casesPrimary site identifiedCommon primary site (no.)
Blaszyk [10]64Adenocarcinoma (51), squamous carcinoma (3)6435Pancreas (13), intestine (11), lung (8), ovaries (1), prostate (1)
Mayordomo [11]43Adenocarcinoma (23), undifferentiated (4), squamous carcinoma (3)4335Bile duct (7), pancreas (6), lung (4), prostate (3), stomach (2)
Maiche [12]109Adenocarcinoma (37), squamous carcinoma (33), undifferentiated (31)6443Lung (13), kidney (6), pancreas (4), intestine (4), liver (3)
Al-Brahim [9]53Adenocarcinoma (37), undifferentiated (5)5327Lung (7), pancreas (4), stomach (3), bile duct (1), appendix (1)
Recent literature summary of studies of patients with cancer of unknown primary The reason why we failed to detect this intrahepatic cholangiocarcinoma using many imaging modalities is considered as follows. Because cardiac pulsation can interfere with diagnostic imaging, it may be difficult to detect the solid tumor in the subphrenic area of the lateral segment of the liver. This area should be considered as one of the blind spots of imaging examination. There were no abnormal findings which could indicate the existence of the cancer lesion from the retrospective viewpoints. If an exploratory laparoscopy was performed, we might have found this intrahepatic cholangiocarcinoma. The result of the immunohistochemistry of the axillary lymph node was accurate in this case, so the treatment choice of chemotherapy with gemcitabine and cisplatin was adequate.

Conclusions

Despite advances in diagnostic imaging technology, identifying the primary sites in patients with metastatic malignancies is sometimes difficult even now. In the presented case, immunohistochemistry was accurate and useful, and exploratory laparoscopy may play a significant role to detect the primary lesion. Thus, various examinations should be performed for CUP patients to receive sufficient treatment.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
  17 in total

Review 1.  Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.

Authors:  F Anthony Greco
Journal:  Curr Treat Options Oncol       Date:  2013-12

2.  Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.

Authors:  Irene Thomassen; Rob H A Verhoeven; Yvette R B M van Gestel; Agnes J van de Wouw; Valery E P P Lemmens; Ignace H J T de Hingh
Journal:  Eur J Cancer       Date:  2013-09-03       Impact factor: 9.162

Review 3.  Maximizing the benefits of autopsy for clinicians and families. What needs to be done.

Authors:  S J McPhee
Journal:  Arch Pathol Lab Med       Date:  1996-08       Impact factor: 5.534

4.  The autopsy. An antidote to misdiagnosis.

Authors:  S J McPhee
Journal:  Medicine (Baltimore)       Date:  1996-01       Impact factor: 1.889

5.  The autopsy as a performance measurement tool--diagnostic discrepancies and unresolved clinical questions: a College of American Pathologists Q-Probes study of 2479 autopsies from 248 institutions.

Authors:  R J Zarbo; P B Baker; P J Howanitz
Journal:  Arch Pathol Lab Med       Date:  1999-03       Impact factor: 5.534

Review 6.  Cancer of unknown primary site: missing primary or missing biology?

Authors:  George Pentheroudakis; Evangelos Briasoulis; Nicholas Pavlidis
Journal:  Oncologist       Date:  2007-04

7.  Cancer of unknown primary. A retrospective study based on 109 patients.

Authors:  A G Maiche
Journal:  Am J Clin Oncol       Date:  1993-02       Impact factor: 2.339

8.  A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.

Authors:  Asuka Tsuya; Takayasu Kurata; Akihiro Tamiya; Isamu Okamoto; Shinya Ueda; Daisuke Sakai; Naotoshi Sugimoto; Koji Matsumoto; Isao Goto; Nobuyuki Yamamoto; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  Invest New Drugs       Date:  2013-08-24       Impact factor: 3.850

9.  Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?

Authors:  Leukothea Dova; George Pentheroudakis; Ioannis Georgiou; Vassiliki Malamou-Mitsi; George Vartholomatos; George Fountzilas; Nikolaos Kolaitis; Evangelia Kitsiou; Nicholas Pavlidis
Journal:  Clin Exp Metastasis       Date:  2007-03-28       Impact factor: 4.510

10.  Neoplasms of unknown primary site: a clinicopathological study of autopsied patients.

Authors:  J I Mayordomo; J M Guerra; C Guijarro; M D García-Prats; A Gómez; M López-Brea; R González; P Hergueta; M A López-Pino; F Martínez-Tello
Journal:  Tumori       Date:  1993-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.